U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute (NCI) announces the availability of funding for implementation of the NCI Experimental Therapeutics-Clinical Trials Network With Phase 1 Emphasis (UM1) Grant. The purpose of this grant is to support an experimental therapeutics clinical trials program through the creation of a consolidated, integrated NCI Experimental Therapeutics-Clinical Trials Network. Contractors should refer to Section VII, Agency Contacts in the RFP, for information regarding each Institute's grants management contact for this program . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | February 11, 2013

Federal Government Announces NCI Experimental Therapeutics-Clinical Trials Network With Phase 1 Emphasis (UM1) Grant Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member